tradingkey.logo

Rapid Micro Biosystems Inc

RPID
View Detailed Chart

3.370USD

+0.150+4.66%
Close 09/19, 16:00ETQuotes delayed by 15 min
148.48MMarket Cap
LossP/E TTM

Rapid Micro Biosystems Inc

3.370

+0.150+4.66%
Intraday
1m
30m
1h
D
W
M
D

Today

+4.66%

5 Days

+11.40%

1 Month

+36.99%

6 Months

+46.52%

Year to Date

+274.44%

1 Year

+287.80%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a very weak stock market performance, the company shows strong technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
64 / 207
Overall Ranking
147 / 4720
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 4 analysts
Buy
Current Rating
8.000
Target Price
+148.45%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission critical automation solutions to facilitate the manufacturing and release of healthcare products, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The Company's flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control, testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 63.72% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 28.05M.
Undervalued
The company’s latest PE is -3.37, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 28.04M shares, increasing 6.35% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 904.36K shares of this stock.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission critical automation solutions to facilitate the manufacturing and release of healthcare products, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The Company's flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control, testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.
Ticker SymbolRPID
CompanyRapid Micro Biosystems Inc
CEOMr. Robert (Rob) Spignesi
Websitehttps://www.rapidmicrobio.com/
KeyAI